Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis

American Journal of Medicine

Volumn 106, Issue 5, 1999, Pages 527-533

  Kyndt, Xavier ^a   Reumaux, Dominique ^a   Bridoux, Franck ^a   Tribout, Bruno ^c   Bataille, Pierre ^b   Hachulla, Eric ^c   Hatron, Pierre Yves ^c   Duthilleul, Patrick ^a   Vanhille, Philippe ^a  

^a CENTRE HOSPITALIER DE VALENCIENNES   (France)

^b Centre Hospitalier de Boulogne sur mer   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; PROTEINASE INHIBITOR; STEROID;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEASUREMENT; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RELAPSE; SYSTEMIC VASCULITIS; WEGENER GRANULOMATOSIS;

AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ARTERITIS; ENDOPEPTIDASES; FEMALE; HUMANS; MALE; MIDDLE AGED; PEROXIDASE; PREDICTIVE VALUE OF TESTS; RECURRENCE; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0033135768     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00064-9     Document Type: Article

References (28)

1. Jayne D.R.W., Gaskin G., Pusey C.D., Lockwood C.M. ANCA and predicting relapse in systemic vasculitis. Q J Med. 88:1995;127-133.
2. van der Woude F.J., Rasmussen N., Lobatto S., et al. Autoantibodies against neutrophils and monocytes a new tool for diagnosis and marker of disease activity in Wegener's granulomatosis . Lancet. i:1985;425-429.
3. Lesavre P., Noël L.H., Chauveau D., et al. Antigen specificities and clinical distribution of ANCA in kidney diseases. Klin Wochenschr. 69:1991;552-557.
4. Kallenberg C.G.M., Brouwer E., Weening J.J., Cohen Tervaert J.W. Anti-neutrophil cytoplasmic antibodies current diagnostic and pathophysiological potential . Kidney Int. 46:1994;1-15.
5. Nölle B., Specks U., Lüdemann J., et al. Anticytoplasmic autoantibodies their immunodiagnostic value in Wegener granulomatosis . Ann Intern Med. 111:1989;28-40.
6. Cohen Tervaert J.W., van der Woude F.J., Fauci A.S., et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med. 149:1989;2461-2465.
7. Specks U., Wheatley C.L., McDonald T.J., et al. Anticytoplasmic autoantibodies in the diagnosis and follow-up of Wegener's granulomatosis. Mayo Clin Proc. 64:1989;28-36.
8. Kerr G.S., Fleisher T.A., Hallahan C.W., et al. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum. 36:1993;365-371.
9. Cohen Tervaert J.W., Huitema M.G., Hené R.J., et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet. 336:1990;709-711.
10. Hoffman G.S., Kerr G.S. Rise in ANCA titer to treat or not to treat? Med. 98:1995;102-103.
11. Jennette J.C., Falk R.J., Andrassy K., et al. Nomenclature of systemic vasculitides proposal of an International Consensus Conference . Arthritis Rheum. 37:1994;187-192.
12. Gaskin J., Pusey C.D. Systemic vasculitis. Cameron J.S., Davison A.M., Grünfeld J.P., Kerr D., Ritz E., Oxford Textbook of Clinical Nephrology. 1992;612-636 Oxford University Press, Oxford, UK.
13. Luqmani R.A., Bacon P.A., Moots R.J., et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med. 87:1994;671-678.
14. Bacon P.A., Moots R.J., Exley A., Luqmani R., Rasmussen N. VITAL assessment of vasculitis workshop report . Clin Exp Rheum. 13:1995;275-278.
15. Cohen Tervaert J.W., van der Molen L., Sluiter W.J., et al. A comparison of three different disease activity scores in patients with different forms of vasculitides. Clin Exp Immunol. 101:1995;42.
16. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. Acta Patholog Microbiolog Immunol Scandinav. 97:(suppl 1):1989;12-13.
17. Hoffman G.S., Kerr G.S., Leavitt R.Y., et al. Wegener's granulomatosis an analysis of 158 patients . Ann Intern Med. 116:1992;488-498.
18. Gordon M., Luqmani R.A., Adu D., et al. Relapses in patients with a systemic vasculitis. Q J Med. 86:1993;779-789.
19. Nachman P.H., Hogan S.L., Jennette J.C., Falk R.J. Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol. 7:1996;33-39.
20. Gaskin G., Savage C.O.S., Ryan J.J., et al. Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis. Nephrol Dial Transplant. 6:1991;689-694.
21. Stegeman C.A., Cohen Tervaert J.W., Sluiter W.J., et al. Association of chronic nasal carriage of staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med. 120:1994;12-17.
22. De'Oliveira J., Gaskin G., Dash A., et al. Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis. Am J Kidney Dis. 25:1995;380-389.
23. Pettersson E., Heigl Z. Antineutrophil cytoplasmic antibody (cANCA and pANCA) titers in relation to disease activity in patients with necrotizing vasculitis a longitudinal study . Clin Nephrol. 37:1992;219-228.
24. Franssen C.F.M., Stegeman C.A., Oost-Kort W., et al. Persistently high levels of antibodies to myeloperoxidase (MPO) are predictive of poor renal outcome in patients with anti-MPO associated glomerulonephritis (GN). Sarcoidosis Vasc Diffuse Lung Dis. 13:1996;274.
25. Cohen Tervaert J.W., Stegeman C.A., Huitema M.G., Kallenberg C.G.M. Relationship between antineutrophil cytoplasmic antibody levels and disease activity in Wegener's granulomatosis comment on the article by Kerr et al . Arthritis Rheum. 37:1994;596.
26. Kerr G., Hoffman G.S. Relationship between antineutrophil cytoplasmic antibody levels and disease activity in Wegener's granulomatosis Reply . Arthritis Rheum. 37:1994;596-597.
27. Davenport A., Lock R.J., Wallington T. Clinical significance of the serial measurement of autoantibodies to neutrophil cytoplasm using a standard indirect immunofluorescence test. Am J Nephrol. 15:1995;201-207.
28. Hagen E.C., Daha M.R., Hermans J., et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int. 53:1998;743-753.